MRVI

6.9952.71%
CD

Christine Dolan

Executive VP & GM of Cygnus Technologies

Ms. Christine Dolan is Executive Vice President and General Manager of Cygnus Technologies since January 1, 2024. She was Executive Vice President of Biologics Safety Testing at Maravai LifeSciences Holdings, Inc. since 2023 until January 1, 2024 and had been its Chief Operating Officer of Biologics Safety Testing since October 2017 until December 2023. She serves as Chief Operating Officer of Biologics Safety Testing Segment at Maravai Life Sciences Inc. since October 2017. Ms. Dolan has been Chief Operating Officer of Biologics Safety Testing at Maravai Topco Holdings, LLC (formerly known as Maravai Life Sciences Holdings, LLC) since October 2017. She serves as Chief Operating Officer at Cygnus Technologies since May 2015. Ms. Dolan has served as Executive Vice President and General Manager, Cygnus Technologies since January 1, 2024. Ms. Dolan served as Senior Vice President of Product Development at Catalent, Inc. since September 2016 until October 17, 2017. Ms. Dolan oversaw Catalent’s innovation and new product development teams. Prior to this appointment, she served as Vice President of Catalent’s global softgel operations with responsibility for 11 softgel manufacturing and development sites. She joined Catalent in October of 2009 in a global quality role. In February of 2010 she was appointed General Manager for Catalent’s Woodstock, IL sterile technologies facility, where she successfully led the site back into solid regulatory compliance and built a sustainable leadership organization. Following Catalent’s acquisition of Aptuit’s clinical supply business in 2011, she was named Vice President and General Manager of the development and analytical business unit with operations in Kansas City, Mo. Raleigh (RTP), NC and Swindon, UK. She began her career as a microbiologist for Smith and Nephew Solopak. In 1995 she joined Amersham Health (acquired by GE Healthcare in 2004) where she served in a series of progressive leadership roles. Prior to joining Catalent Pharma Solutions, Ms. Dolan was Director of Nuclear Operations and Global Quality Control at GE Healthcare. In 2000, she was named the Director of QC and Materials Management, subsequently expanding her responsibilities to include supply chain, EHS, logistics, customer service and validation. In 2008 she was named Global Quality Operations Director with responsibilities in Germany, Netherlands, the UK and US. She holds a BS in Biology from Lenoir-Rhyne College. Ms. Dolan held several operational and business leadership roles, including Senior Vice President of Product Development, VP of Global Operations and VP GM of Development and Analytical Services, at Catalent Pharma Solutions, a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products, where Ms. Dolan worked for over eight years.

Positions